Erik Amble Net Worth

Erik Amble biography

Erik Amble Ph.D. serves as Independent Director of the Company. From October 2018 to April 2019, Mr. Amble served as a member of our nominating and corporate governance committee and since April 2019, Mr. Amble has returned to serving as a member of our audit committee. Since July 2001, Mr. Amble has served as Chair of NeoMed Management (Jersey) Limited, the manager of NeoMed Innovation V L.P., a venture capital firm focused on supporting entrepreneurs and businesses in the healthcare industry. Mr. Amble holds a Ph.D. in Organic Chemistry from the University of Oslo and an M.Sc. in Management from the Graduate School of Business, Stanford University.

What is the salary of Erik Amble?

As the Independent Director of Axonics Inc, the total compensation of Erik Amble at Axonics Inc is $565,081. There are 10 executives at Axonics Inc getting paid more, with Raymond Cohen having the highest compensation of $6,147,640.

How old is Erik Amble?

Erik Amble is 68, he's been the Independent Director of Axonics Inc since 2014. There are no older and 21 younger executives at Axonics Inc.

What's Erik Amble's mailing address?

Erik's mailing address filed with the SEC is 26, Technology Drive, Irvine Spectrum, Irvine, Orange County, California, 92618, United States.

Insiders trading at Axonics Inc

Over the last 6 years, insiders at Axonics Inc have traded over $108,010,643 worth of Axonics Inc stock and bought 4,672,163 units worth $70,180,620 . The most active insiders traders include Asset Management, Lp Chen B..., Shahzad Malik, and Geoff Pardo. On average, Axonics Inc executives and independent directors trade stock every 15 days with the average trade being worth of $4,280,711. The most recent stock trade was executed by Raymond W Cohen on 24 July 2024, trading 103,896 units of AXNX stock currently worth $2,383,374.

What does Axonics Inc do?

axonics modulation technologies, inc is a privately-held medical device company developing an innovative neuromodulation platform based on a miniaturized rechargeable fully-implantable ipg licensed from the alfred mann foundation. the axonics sacral neuromodulation system is designed to improve the experience of both clinicians and patients suffering from urinary and fecal dysfunction.

Axonics Inc executives and stock owners

Axonics Inc executives and other stock owners filed with the SEC include:

• Raymond Cohen,
  Chief Executive Officer, Director
• Dan Dearen,
  President, Chief Financial Officer
• Rinda Sama,
  Chief Operating Officer
• Raymond W. Cohen,
  CEO & Director
• Danny L. Dearen,
  Pres & CFO
• Dr. Karen L. Noblett M.D., M.A.S.,
  Chief Medical Officer
• Rinda K. Sama,
  Chief Operating Officer
• Robert McNamara,
  Independent Director
• Juliet Tammenoms Bakker,
  Independent Director
• Alfred J. Ford Jr.,
  Chief Commercial Officer
• Erik Amble,
  Independent Director
• Michael Carrel,
  Independent Chairman of the Board
• Jane Kiernan,
  Independent Director
• Nancy Snyderman,
  Independent Director
• Karen Noblett,
  Chief Medical Officer
• Prabodh Mathur,
  Chief Product Development Officer
• Alfred Ford,
  Chief Commercial Officer
• John Woock,
  Chief Marketing Officer
• Dr. Karen L. Noblett M.A.S., M.D.,
  Chief Medical Officer
• Michael V. Williamson Esq., J.D.,
  Sr. VP, Gen. & IP Counsel
• Michael V. Williamson,
  Sr. VP, Gen. & IP Counsel
• Dr. John Woock Ph.D.,
  Exec. VP, Chief Marketing & Strategy Officer
• Aaron Pettit,
  Gen. Counsel & Chief Compliance Officer
• Neil Bhalodkar,
  VP of Investor Relations
• Guangqiang Jiang Ph.D.,
  Chief Technology Officer
• Esteban Lopez,
  
• John George Petrovich,
  Director
• Shahzad Malik,
  Director
• Life Sciences Llp Advent Li...,
  
• Partners Bio Discovery 4 Fc...,
  
• E. Mann Foundation For Scie...,
  
• Capital Partners Iii, Llcen...,
  
• Innovation V Ltd Neo Med In...,
  
• Healthcare Holding B.V.Gild...,
  
• Asset Management, Lp Chen B...,
  
• Michael V. Williamson,
  SVP, General Counsel
• Guangqiang Jiang,
  Chief Technology Officer
• Zhong Zac & Cloud Holdings ...,
  
• Raphael Wisniewski,
  
• Robert E Mcnamara,
  
• Geoff Pardo,
  
• David M Demski,
  
• Kari Leigh Keese,
  Chief Financial Officer